AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 11/06/20

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Amneal Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation

Amneal Pharmaceuticals (AMRX): Q3 Non-GAAP EPS of $0.16 beats by $0.04; GAAP EPS of -$0.06 misses by $0.05.Revenue of $519.29M (+37.3% Y/Y) beats by $37.07M.Press Release For further details see: Amneal Pharmaceuticals EPS beats by $0.04, beats on revenue

‒ Q3 2020 Net Revenue of $519 million; GAAP Net Loss of $(9) million; Diluted Loss per Share of $(0.06) ‒ ‒ Q3 2020 Adjusted Net Income (1) of $49 million; Adjusted EBITDA (1) of $114 million; Adjusted Diluted EPS (1) of $0.16‒ ...

Amneal Pharmaceuticals (NYSE:AMRX) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is $0.12 (+200.0% Y/Y) and the consensus Revenue Estimate is $482.22M (+27.5% Y/Y).Over the last 2 years, AMRX has beaten EPS estimates 63% ...

[[AES]], [[AMRX]], [[COTY]], [[CQP]], [[CVS]], [[CWT]], [[DISH]], [[DOC]], [[ELAN]], [[ENB]], [[EPZM]], [[ESNT]], [[GCP]], [[GOLF]], [[HMSY]], [[HRC]], [[HSY]], [[LNG]], [[MAR]], [[MBUU]], [[MD]], [[MGA]], [[MOG.A]], [[MYL]], [[PRIM]], [[SABR]], [[SSP]], [[TILE]], [[TU]], [[UFS]], [[VIAC]], [...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2020 financial results on Friday, November 6, 2020, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern...

Amneal Pharmaceuticals, Inc. (NYSE:AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, work...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand equivalent Voltaren® Arthritis Pain Gel (diclofenac sodium topical gel, 1%) in 50, 100 and 1...

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with this Read more ...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that members of management will participate at the Morgan Stanley Global Healthcare Conference held on September 15, 2020. The presentation will begin at 4:15 PM Eastern Time and a live webcast will be acc...